Drug Research

A private biotechnology startup called Arsenal Biosciences will receive $70 million from Roche in exchange for access to technology that the two businesses believe will enable them to reroute immune cells to attack cancer. According to the agreement, which was...

Daiichi Sankyo, a Japanese company, has been concentrating on a series of antibody-drug conjugates, but it has achieved a world first in a field that Pfizer is also pursuing. The Japanese government has given Daiichi Sankyo permission to use...

Despite the fact that the decision to severely restrict coverage of an expensive new Alzheimer's medicine, U.S. President Joe Biden celebrated success on September 27th by claiming that expenditures for tens of millions of Americans enrolled in the Medicare...

In order to ultimately enhance the outcomes and care for children and people with chronic conditions, especially as novel variants emerge, the Australian government is funding a new study on COVID-19 vaccinations and infection. The new PROPHECY study, directed by...

The Critical Path for Rare Neurodegenerative Diseases (CP-RND), a new public-private partnership created to advance the development of treatments for amyotrophic lateral sclerosis (ALS) and similar rare neurodegenerative conditions, has been initiated by the US Food and Drug Administration...

A quarter of patients with a variety of advanced tumours have shown signals of benefit from RP2, a modified form of the herpes simplex virus, according to research. The trial's participants had malignancies of the head and neck, oesophagus,...

The fixed-dose combination Opdualag (nivolumab and relatlimab) from Bristol Myers Squibb (BMS) has received clearance from the European Commission for use as the first-line therapy for advanced unresectable or metastatic melanoma. Patients aged 12 years and older who have cancer...